It is thought that dead cancer cells and tumor debris serve as antigen sources for XP by cDC1, but it remains unclear whether the handling and processing of such antigens imposes an antigen selection bias that can impact the epitope repertoire of effector anti-tumor T cells. The gene discussed is MPPE1; the disease is cancer.